U.S. Markets closed
  • S&P 500

    +8.26 (+0.19%)
  • Dow 30

    +13.40 (+0.04%)
  • Nasdaq

    +49.12 (+0.35%)
  • Russell 2000

    +24.40 (+1.06%)
  • Crude Oil

    +0.49 (+0.70%)
  • Gold

    -16.90 (-0.89%)
  • Silver

    +0.02 (+0.07%)

    -0.0065 (-0.5329%)
  • 10-Yr Bond

    +0.0030 (+0.21%)
  • Vix

    -0.45 (-2.80%)

    -0.0060 (-0.4221%)

    +0.2760 (+0.2524%)

    +1,552.25 (+4.32%)
  • CMC Crypto 200

    -17.62 (-1.87%)
  • FTSE 100

    +45.88 (+0.65%)
  • Nikkei 225

    -9.87 (-0.03%)

Positive Global Healthcare Outlook Could Push 3 Stocks Higher

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

CORAL GABLES, FL / ACCESSWIRE / October 30,2018 / new reports from Deloitte, Exponential technologies are driving less expensive, more efficient, and more accessible care delivery on a global scale. The report cites that "exponentials will reshape health care by impacting areas such as synthetic biology, 3D printing and nanotechnology, and companion diagnostics amongst others."

Furthermore, Deloitte says that digital technology, robotics, and other automated tools have "enormous potential" to resolve current and future healthcare workforce pain points. Health care providers should embrace strategies where talent can collaborate with technology to improve efficiency instead of competing against each other.

As Deloitte points out, as global health care spending is projected to reach $8.7 trillion by 2020, companies like Premier Health Group, Inc. (PHGRF)(PHGI.CN), Reliq Health Technologies (TSX-V:RHT.V)(RQHTF) and Oragenics, Inc. (NYSE American: OGEN) are in focus on Tuesday

Premier Health Group, Inc. (PHGRF)(PHGI.CN) is a company focused on developing innovative healthcare approaches that combine human skill-based expertise with emerging technologies for the healthcare industry. Premier Health Group, Inc. (PHGRF)(PHGI.CN) acquired HealthVue Medical Clinics in August. With this acquisition, Premier was able to enter the primary care clinic and healthcare technology business. HealthVue is a group of four Greater Vancouver-based fully integrated, paperless and electronic-medical-record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients. The clinics have seen revenue growth in excess of 25 percent year over year for the past three years and thus far accounted for over 36,000 patient visits in 2018. HealthVue will open its fifth clinic in Q4 2018.

Furthmore, Premier Health Group, Inc. (PHGRF)(PHGI.CN) expansion plans include new clinic openings, acquisitions (clinic, technologyand patients), cannabis clinic(s) and partnerships. Just last week Premier Health Group, Inc. (PHGRF)(PHGI.CN) announced that its common shares traded on the OTC Markets Group Inc.'s OTCQB Venture Market in the United States, under the symbol PHGRF, are Depository Trust Company eligible, effective Oct. 22, 2018.

For More Information On Premier Health Group, Click Here

Reliq Health Technologies (RHT.V)(RQHTF) is a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market. The company recently selected Premier Health Group (above) as its exclusive technology partner. Reliq will be providing Premier's HealthVue primary care clinics with a HealthVue-branded telemedicine, remote monitoring & AI solution for its clinical staff and more than 100,000 active patients.

Reliq has also announced this month that the Chief Visionary Officer Mr. Giancarlo De Lio is no longer employed by the Company. In addition, the Company noted that it has engaged Sophic Capital as its Investor Relations firm. Sophic Capital is a comprehensive capital markets advisory firm focused on microcap growth companies.

Shares of the company were up by more than 25% during the morning trading session on Tuesday

For More Information On Reliq, Click Here

Oragenics, Inc. (OGEN) is focused on the development of new antibiotics against infectious diseases and effective treatments for oral mucositis ("OM"). This month the company announced that it has received clearance to enroll patients residing in Belgium from the Belgian Health Authority, The Federal Agency for Medicines and Health Products (FAMHP), into its Phase 2 clinical trial of AG013, a live biotherapeutic product for the potential prevention and treatment of OM.

"Enrolling patients outside of the United States provides an expansive patient base from which to draw for our trial of AG013, allowing us to more rapidly reach our goal of enrolling between 160-180 evaluable patients," stated Alan Joslyn, Ph.D., president, and CEO of Oragenics, Inc. "The combination of the expanded number of clinical sites in the United States and Europe along with recent warrant exercises generating proceeds of approximately $9.5 million, should enhance our ability to complete the clinical study in 2019."

Shares of the company have taken off on Tuesday and have already moved to highs of $1.25 as of this article.

For More Information On Oragenics, Click Here

What Is Stock Price (StockPrice.com)?

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.

StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2018 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid "500,000" shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6)Six month restriction is complete on 4/1/2018 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

*Deloitte Report: https://www2.deloitte.com/global/en/pages/life-sciences-and-healthcare/articles/global-health-care-sector-outlook.html.

Contact Information:


SOURCE: StockPrice.com